C76.42

Clinical Causes: Genetic mutations within cells leading to uncontrolled growth Exposure to carcinogens such as chemicals, radiation, or certain environmental toxins Chronic inflammation or injury to the limb tissue Pre-existing benign tumors that transform into malignant ones Personal or family history of skin or bone cancers Prolonged ultraviolet (UV) exposure, especially for skin cancers in the upper limb

Key Symptoms: A persistent lump, mass, or swelling in the affected limb Unexplained pain or tenderness in the area Changes to the skin, such as ulceration, color changes, or increased lesion size Numbness or tingling sensations if nerves are involved Limited movement or function of the limb due to tumor growth or pain Skin ulceration or bleeding over the tumor site Unintentional weight loss or fatigue in advanced stages

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy procedures. Initial assessment may include physical examination and medical history. Imaging techniques such as X-rays, MRI, or CT scans help determine the tumor’s size, location, and extent. A biopsy, where a tissue sample is examined microscopically, confirms malignancy and identifies the cancer type, which guides treatment planning.

Treatment Protocols: Treatment options depend on the tumor’s size, location, stage, and overall health of the patient. Common approaches include: - Surgical removal of the tumor and surrounding tissues to achieve clear margins - Radiation therapy aimed at destroying cancer cells in the affected area - Chemotherapy, especially if there is a risk of metastasis or local recurrence - Targeted therapy or immunotherapy in specific cases based on genetic or molecular characteristics - Rehabilitation and supportive care to restore limb function and address side effects A multidisciplinary team usually manages treatment, aiming for optimal outcomes and quality of life.